ReviewMolecules (Basel, Switzerland)2026
Chemical Composition, Biological Activities and Application of
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lupins have been cultivated since ancient times. Poland ranks second in the world in terms of lupin cultivation area (second only to Australia), particularly for narrow-leaved lupin. It is used in various industries. The purpose of this review is to analyze data on the chemical composition of narrow-leaved lupin in comparison with other species of this genus, as well as to identify its potential applications. The literature data characterize narrow-leaved lupin in terms of its content of protein, lectins, fat, carotenoids, phytosterols, fiber, sugars, alkaloids, vitamins, flavonoids, phenolic compounds, volatile organic compounds, and micro- and macronutrients. Due to its interesting qualitative and quantitative composition, this species may play a significant role in human nutrition-not only as an alternative source of protein, but above all as a source of health-promoting compounds. Studies conducted on humans and animals have demonstrated a wide range of biological effects, including anti-inflammatory, antioxidant and cholesterol-lowering effects. In addition, in vitro studies suggest anticancer effects. Among the tangible outcomes of research and commercialization efforts is the availability on the consumer market of food and cosmetic products containing lupin. Due to its properties, this species has a wide range of applications. However, to meet the requirements of various industrial sectors, a collaborative approach is necessary among plant breeders, scientists, and industry representatives working to improve this species. Only through joint efforts can the use of narrow-leaved lupin be expanded.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.